Cargando…

Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)

OBJECTIVE: This study sought to evaluate whether synthetic data derived from a national coronavirus disease 2019 (COVID-19) dataset could be used for geospatial and temporal epidemic analyses. MATERIALS AND METHODS: Using an original dataset (n = 1 854 968 severe acute respiratory syndrome coronavir...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Jason A, Foraker, Randi E, Zamstein, Noa, Morrow, Jon D, Payne, Philip R O, Wilcox, Adam B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992357/
https://www.ncbi.nlm.nih.gov/pubmed/35357487
http://dx.doi.org/10.1093/jamia/ocac045
_version_ 1784683713200652288
author Thomas, Jason A
Foraker, Randi E
Zamstein, Noa
Morrow, Jon D
Payne, Philip R O
Wilcox, Adam B
author_facet Thomas, Jason A
Foraker, Randi E
Zamstein, Noa
Morrow, Jon D
Payne, Philip R O
Wilcox, Adam B
author_sort Thomas, Jason A
collection PubMed
description OBJECTIVE: This study sought to evaluate whether synthetic data derived from a national coronavirus disease 2019 (COVID-19) dataset could be used for geospatial and temporal epidemic analyses. MATERIALS AND METHODS: Using an original dataset (n = 1 854 968 severe acute respiratory syndrome coronavirus 2 tests) and its synthetic derivative, we compared key indicators of COVID-19 community spread through analysis of aggregate and zip code-level epidemic curves, patient characteristics and outcomes, distribution of tests by zip code, and indicator counts stratified by month and zip code. Similarity between the data was statistically and qualitatively evaluated. RESULTS: In general, synthetic data closely matched original data for epidemic curves, patient characteristics, and outcomes. Synthetic data suppressed labels of zip codes with few total tests (mean = 2.9 ± 2.4; max = 16 tests; 66% reduction of unique zip codes). Epidemic curves and monthly indicator counts were similar between synthetic and original data in a random sample of the most tested (top 1%; n = 171) and for all unsuppressed zip codes (n = 5819), respectively. In small sample sizes, synthetic data utility was notably decreased. DISCUSSION: Analyses on the population-level and of densely tested zip codes (which contained most of the data) were similar between original and synthetically derived datasets. Analyses of sparsely tested populations were less similar and had more data suppression. CONCLUSION: In general, synthetic data were successfully used to analyze geospatial and temporal trends. Analyses using small sample sizes or populations were limited, in part due to purposeful data label suppression—an attribute disclosure countermeasure. Users should consider data fitness for use in these cases.
format Online
Article
Text
id pubmed-8992357
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89923572022-04-12 Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C) Thomas, Jason A Foraker, Randi E Zamstein, Noa Morrow, Jon D Payne, Philip R O Wilcox, Adam B J Am Med Inform Assoc Research and Applications OBJECTIVE: This study sought to evaluate whether synthetic data derived from a national coronavirus disease 2019 (COVID-19) dataset could be used for geospatial and temporal epidemic analyses. MATERIALS AND METHODS: Using an original dataset (n = 1 854 968 severe acute respiratory syndrome coronavirus 2 tests) and its synthetic derivative, we compared key indicators of COVID-19 community spread through analysis of aggregate and zip code-level epidemic curves, patient characteristics and outcomes, distribution of tests by zip code, and indicator counts stratified by month and zip code. Similarity between the data was statistically and qualitatively evaluated. RESULTS: In general, synthetic data closely matched original data for epidemic curves, patient characteristics, and outcomes. Synthetic data suppressed labels of zip codes with few total tests (mean = 2.9 ± 2.4; max = 16 tests; 66% reduction of unique zip codes). Epidemic curves and monthly indicator counts were similar between synthetic and original data in a random sample of the most tested (top 1%; n = 171) and for all unsuppressed zip codes (n = 5819), respectively. In small sample sizes, synthetic data utility was notably decreased. DISCUSSION: Analyses on the population-level and of densely tested zip codes (which contained most of the data) were similar between original and synthetically derived datasets. Analyses of sparsely tested populations were less similar and had more data suppression. CONCLUSION: In general, synthetic data were successfully used to analyze geospatial and temporal trends. Analyses using small sample sizes or populations were limited, in part due to purposeful data label suppression—an attribute disclosure countermeasure. Users should consider data fitness for use in these cases. Oxford University Press 2022-05-13 /pmc/articles/PMC8992357/ /pubmed/35357487 http://dx.doi.org/10.1093/jamia/ocac045 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_modelThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
spellingShingle Research and Applications
Thomas, Jason A
Foraker, Randi E
Zamstein, Noa
Morrow, Jon D
Payne, Philip R O
Wilcox, Adam B
Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)
title Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)
title_full Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)
title_fullStr Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)
title_full_unstemmed Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)
title_short Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)
title_sort demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: results from analyzing >1.8 million sars-cov-2 tests in the united states national covid cohort collaborative (n3c)
topic Research and Applications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992357/
https://www.ncbi.nlm.nih.gov/pubmed/35357487
http://dx.doi.org/10.1093/jamia/ocac045
work_keys_str_mv AT thomasjasona demonstratinganapproachforevaluatingsyntheticgeospatialandtemporalepidemiologicdatautilityresultsfromanalyzing18millionsarscov2testsintheunitedstatesnationalcovidcohortcollaborativen3c
AT forakerrandie demonstratinganapproachforevaluatingsyntheticgeospatialandtemporalepidemiologicdatautilityresultsfromanalyzing18millionsarscov2testsintheunitedstatesnationalcovidcohortcollaborativen3c
AT zamsteinnoa demonstratinganapproachforevaluatingsyntheticgeospatialandtemporalepidemiologicdatautilityresultsfromanalyzing18millionsarscov2testsintheunitedstatesnationalcovidcohortcollaborativen3c
AT morrowjond demonstratinganapproachforevaluatingsyntheticgeospatialandtemporalepidemiologicdatautilityresultsfromanalyzing18millionsarscov2testsintheunitedstatesnationalcovidcohortcollaborativen3c
AT paynephilipro demonstratinganapproachforevaluatingsyntheticgeospatialandtemporalepidemiologicdatautilityresultsfromanalyzing18millionsarscov2testsintheunitedstatesnationalcovidcohortcollaborativen3c
AT wilcoxadamb demonstratinganapproachforevaluatingsyntheticgeospatialandtemporalepidemiologicdatautilityresultsfromanalyzing18millionsarscov2testsintheunitedstatesnationalcovidcohortcollaborativen3c
AT demonstratinganapproachforevaluatingsyntheticgeospatialandtemporalepidemiologicdatautilityresultsfromanalyzing18millionsarscov2testsintheunitedstatesnationalcovidcohortcollaborativen3c